These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


159 related items for PubMed ID: 326262

  • 1. A new centrally action antihypertensive agent guanfacine (BS 100-141).
    Dubach UC, Huwyler R, Radielovic P, Singeisen M.
    Arzneimittelforschung; 1977; 27(3):674-6. PubMed ID: 326262
    [Abstract] [Full Text] [Related]

  • 2. Guanfacine: a new centrally-acting antihypertensive agent.
    Beevers DG, Bloxham CA, Walker JM.
    Pharmatherapeutica; 1981; 2(8):513-6. PubMed ID: 7019931
    [Abstract] [Full Text] [Related]

  • 3. Antihypertensive effect of N-amidino-2-(2,6-dichlorophenyl) acetamide hydrochloride. A double-blind cross-over trial versus clonidine.
    Kirch W, Distler A.
    Int J Clin Pharmacol Biopharm; 1978 Mar; 16(3):132-5. PubMed ID: 348614
    [Abstract] [Full Text] [Related]

  • 4. [A new antihypertensive agent used in a clinical setting].
    Wetzels E, Raschig A, Kaiser HJ.
    Med Klin; 1980 Sep 12; 75(19):688-92. PubMed ID: 7001207
    [Abstract] [Full Text] [Related]

  • 5. [Guanfacine versus alpha-methyldopa in benign essential hypertension. An ambulatory group study].
    Rhomberg F, Widler J.
    Schweiz Med Wochenschr; 1981 Dec 12; 111(50):1967-8. PubMed ID: 7036334
    [Abstract] [Full Text] [Related]

  • 6. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
    Malini PL, Strocchi E, Ambrosioni E, Magnani B.
    Int J Clin Pharmacol Res; 1983 Dec 12; 3(1):35-9. PubMed ID: 6384071
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Guanfacine in the treatment of hypertension: two years' experience with low dose monotherapy.
    Jerie P, Lasance A.
    Int J Clin Pharmacol Ther Toxicol; 1981 Jun 12; 19(6):279-87. PubMed ID: 7030975
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
    Farooki MS, Farsky K, Bouchard S, Lalonde Y, Brookman S.
    Clin Ther; 1985 Jun 12; 7(2):199-204. PubMed ID: 3886142
    [Abstract] [Full Text] [Related]

  • 11. [Antihypertensive therapy with guanfacine. A multicenter study with Estulic-Wander 1mg. Determinants of effectiveness and tolerance].
    Schäfer N, Knaup G.
    Med Welt; 1983 Feb 04; 34(5):158-61. PubMed ID: 6341756
    [No Abstract] [Full Text] [Related]

  • 12. [Treatment of arterial hypertension with a single daily dose of guanfacine].
    Jardim PC, Rassi S, Lopes M, Simioni PR, Guimarães E, Maranhão MF, Porto CC.
    Arq Bras Cardiol; 1984 Nov 04; 43(5):365-9. PubMed ID: 6399438
    [No Abstract] [Full Text] [Related]

  • 13. [Clinical pharmacology of the antihypertensive action of guanfacine].
    Safar M, Weiss Y, Georges D.
    Arch Mal Coeur Vaiss; 1980 Oct 04; 73(10):1171-7. PubMed ID: 6778409
    [Abstract] [Full Text] [Related]

  • 14. Long-term efficacy and tolerance of the antihypertensive agent guanfacine.
    Jerie P, Lasance A.
    Int J Clin Pharmacol Ther Toxicol; 1984 Mar 04; 22(3):170-4. PubMed ID: 6370876
    [Abstract] [Full Text] [Related]

  • 15. [Cross-over double-blind study of the antihypertensive action of N-amidino-2-(2,6-dichlorophenyl)acetamide-hydrochloride and clonidine].
    Kirch W, Distler A.
    Verh Dtsch Ges Inn Med; 1984 Mar 04; 83():318-21. PubMed ID: 347806
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Low dose guanfacine and methyldopa in mild essential hypertension. A multiple centre study.
    Viskoper RJ, Laszt A, Paran E, Ben Ari J, Goren Y, Modan M.
    Neth J Med; 1987 Aug 04; 31(1-2):58-65. PubMed ID: 3309693
    [No Abstract] [Full Text] [Related]

  • 18. Long-term clinical experience with guanfacine.
    Fetkovská N, Brimichová G, Sebeková K, Dzúrik R.
    Cor Vasa; 1987 Aug 04; 29(4 Suppl 1):23-9. PubMed ID: 3315447
    [Abstract] [Full Text] [Related]

  • 19. [First experiences with BS 100-141, a new antihypertensive substance].
    Esch I.
    Int J Clin Pharmacol Biopharm; 1976 Sep 04; 14(2):109-12. PubMed ID: 793999
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.